与STEMI相比,大部分NSTEMI患者病变较轻,病情进展也较“温和”,其介入时机的选择需要根据患者的危险评分结果而定,根据患者的临床特点,NSTEMI患者可分为极高危、高危和中危几种类型,具体如下表所示。 表3 NSTEMI患者的冠脉造影和再血管化治疗推荐 参考文献:1. Mitsis A, Gragnano F. Myocardial Infarction with and without ST-segment Elevation: a Contemporary Reappraisal of Similarities and Differences. Curr Cardiol Rev. 2020 Dec 10.2. Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med.2013; 368: 2004-2013.3. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for CardioThoracic Surgery (EACTS). Eur Heart J. 2018; 39: 213–260.4. Collet JP, Thiele H, Barbato E, et al. SC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021; 42(14): 1289-1367.